PT941094E - Processo para o fabrico de suspensoes oftalmicas contendo brinzolamida - Google Patents

Processo para o fabrico de suspensoes oftalmicas contendo brinzolamida

Info

Publication number
PT941094E
PT941094E PT97939835T PT97939835T PT941094E PT 941094 E PT941094 E PT 941094E PT 97939835 T PT97939835 T PT 97939835T PT 97939835 T PT97939835 T PT 97939835T PT 941094 E PT941094 E PT 941094E
Authority
PT
Portugal
Prior art keywords
ophthalmal
manufacture
suspensions containing
brinzolamide
containing brinzolamide
Prior art date
Application number
PT97939835T
Other languages
English (en)
Portuguese (pt)
Inventor
Yusuf Ali
Robert E Beck
Rex C Sport
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of PT941094E publication Critical patent/PT941094E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
PT97939835T 1996-12-11 1997-09-05 Processo para o fabrico de suspensoes oftalmicas contendo brinzolamida PT941094E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3282096P 1996-12-11 1996-12-11
US08/886,933 US6071904A (en) 1996-12-11 1997-07-02 Process for manufacturing ophthalmic suspensions

Publications (1)

Publication Number Publication Date
PT941094E true PT941094E (pt) 2002-05-31

Family

ID=26708929

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97939835T PT941094E (pt) 1996-12-11 1997-09-05 Processo para o fabrico de suspensoes oftalmicas contendo brinzolamida

Country Status (13)

Country Link
US (1) US6071904A (enExample)
EP (1) EP0941094B1 (enExample)
JP (1) JP3611863B2 (enExample)
AT (1) ATE209917T1 (enExample)
CA (1) CA2274680C (enExample)
DE (2) DE69708912T2 (enExample)
DK (1) DK0941094T3 (enExample)
ES (1) ES2169416T3 (enExample)
FR (1) FR09C0022I2 (enExample)
LU (1) LU91554I2 (enExample)
NL (1) NL300388I2 (enExample)
PT (1) PT941094E (enExample)
WO (1) WO1998025620A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001365A1 (en) * 1998-06-30 2000-01-13 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Prolonged release ophthalmic compositions containing a fluoroquinolone
US7112588B2 (en) * 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
MXPA03010634A (es) 2001-05-21 2004-03-09 Alcon Inc Uso de inhibidores de proteasoma para tratar trastornos del ojo seco.
BR0209965A (pt) 2001-05-21 2004-04-06 Alcon Inc Uso de inibidores de nf-kappab para tratar distúrbios do olho seco
JP2004531560A (ja) * 2001-05-21 2004-10-14 アルコン,インコーポレイテッド ドライアイ障害を処置する方法
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
DE60313299T2 (de) * 2002-03-01 2008-01-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Selbstemulgierende systeme zur abgabe von taxoiden
ES2301964T3 (es) 2003-01-21 2008-07-01 Senju Pharmaceutical Co., Ltd. Preparado liquido acuoso que contiene acido 2-amino-3-(4-bromobenzoil)fenilacetico.
DE602005026225D1 (de) * 2004-03-12 2011-03-24 Cipla Ltd Sterilisationsprozess für Steroide
DK1891939T3 (da) * 2006-07-28 2013-10-07 Novagali Pharma Sa Sammensætninger indeholdende kvaternære ammoniumforbindelser
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
TWI489997B (zh) * 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸-多元醇錯合物之水性藥學組成物
MX2012006401A (es) * 2009-12-03 2012-07-10 Lupin Ltd Proceso para preparar composiciones oftalmicas farmaceuticas.
EP2394637A1 (en) * 2010-05-21 2011-12-14 Zaklady Farmaceutyczne Polpharma SA Process for obtaining sterile brinzolamide suspensions
EP2598118B1 (en) 2010-07-29 2018-09-05 Allergan, Inc. Preservative free bimatoprost and timolol solutions
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
WO2012053011A2 (en) 2010-10-18 2012-04-26 Usv Limited Ophthalmic compositions comprising brinzolamide
US20130065888A1 (en) 2011-08-15 2013-03-14 Biserka Cetina-Cizmek Ophthalmic formulations and processes for their preparation
EP2638909A1 (en) 2012-03-15 2013-09-18 Azad Pharmaceutical Ingredients AG Process for preparing sterile Brinzolamide
GR1007906B (el) * 2012-03-22 2013-05-30 Φαρματεν Αβεε, Οφθαλμικο φαρμακευτικο σκευασμα περιεχον ενα αναστολεα καρβονικης ανυδρασης και μεθοδος για την παρασκευη αυτου
CN104487099B (zh) 2012-05-09 2017-06-20 艾科罗姆共同股份公司 无菌的活性药物成分的生产
WO2013175285A1 (en) 2012-05-21 2013-11-28 Aurobindo Pharma Limited Process for preparing ophthalmic suspension of brinzolamde
EP2906198B1 (en) 2012-10-11 2019-04-03 Indoco Remedies Limited A process for manufacturing sterile brinzolamide ophthalmic suspension
CN104721136A (zh) * 2013-02-21 2015-06-24 四川大学 一种布佐林胺眼用纳米混悬剂及其制备方法
UA116273C2 (uk) * 2013-10-17 2018-02-26 Сентісс Фарма Прайвет Лімітед Офтальмологічний фармацевтичний склад, що не містить консерванта
US9820991B2 (en) * 2013-11-08 2017-11-21 Sentiss Pharma Private Limited Pharmaceutical composition comprising brinzolamide
US10463674B2 (en) 2013-11-08 2019-11-05 Sentiss Pharma Private Limited Process for manufacturing sterile ophthalmic pharmaceutical suspensions
EA036820B1 (ru) * 2014-01-24 2020-12-23 Сентисс Фарма Прайвет Лимитед Фармацевтическая композиция, содержащая бринзоламид
PL407710A1 (pl) * 2014-03-28 2015-10-12 Instytut Farmaceutyczny Sposób wytwarzania preparatu kropli do oczu w postaci zawiesiny zawierającej brynzolamid i preparat wytworzony tym sposobem
JP6279395B2 (ja) * 2014-05-01 2018-02-14 東亜薬品株式会社 ブリンゾラミド懸濁性点眼液組成物の製造方法
UA124698C2 (uk) 2014-10-20 2021-11-03 Сентіс Фарма Прайвет Лімітед Офтальмологічний розчин
TWI700085B (zh) 2015-06-22 2020-08-01 新源生物科技股份有限公司 酪胺酸激酶抑制劑之眼用調配物的用途
CN107582519A (zh) * 2017-06-01 2018-01-16 合肥远志医药科技开发有限公司 一种布林佐胺滴眼液制剂及其制备方法
GR1009419B (el) 2017-11-07 2018-12-14 Φαρματεν Αβεε Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου
JP2021521240A (ja) 2018-04-25 2021-08-26 シルパ メディケア リミテッドShilpa Medicare Limited ブリンゾラミドの眼科用組成物
GR1009616B (el) * 2018-07-20 2019-10-11 Φαρματεν Α.Β.Ε.Ε. Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει βρινζολαμιδη και τιμολολη και μεθοδος παρασκευης αυτου
WO2020240451A1 (en) 2019-05-29 2020-12-03 Lupin Limited In-situ gelling nanoemulsion of brinzolamide
US11850249B2 (en) 2020-10-05 2023-12-26 Somerset Therapeutics, Llc Methods of efficiently reducing intraocular pressure
WO2024236599A1 (en) 2023-05-16 2024-11-21 Micro Labs Limited Ophthalmic solution of brinzolamide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
SK282039B6 (sk) * 1991-04-17 2001-10-08 Merck & Co., Inc. Oftalmický prípravok na liečenie očnej hypertenzie obsahujúci kombináciu inhibítora karboanhydrázy a beta-adrenergného antagonistu
ATE169499T1 (de) * 1992-02-21 1998-08-15 Alcon Lab Inc Topische antiglaukoma zusammensetzungen, enthaltend karbonhydrasehemmer und beta-blocker
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
US5346702A (en) * 1992-12-04 1994-09-13 Sterling Winthrop Inc. Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
US5429824A (en) * 1992-12-15 1995-07-04 Eastman Kodak Company Use of tyloxapole as a nanoparticle stabilizer and dispersant
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system

Also Published As

Publication number Publication date
JP3611863B2 (ja) 2005-01-19
ES2169416T3 (es) 2002-07-01
FR09C0022I1 (enExample) 2009-09-25
AU718079B2 (en) 2000-04-06
NL300388I1 (nl) 2009-07-01
WO1998025620A1 (en) 1998-06-18
JP2000501749A (ja) 2000-02-15
DK0941094T3 (da) 2002-01-07
NL300388I2 (nl) 2010-02-01
ATE209917T1 (de) 2001-12-15
CA2274680A1 (en) 1998-06-18
US6071904A (en) 2000-06-06
EP0941094A1 (en) 1999-09-15
AU4183897A (en) 1998-07-03
DE69708912T2 (de) 2002-04-11
LU91554I2 (fr) 2009-06-22
FR09C0022I2 (enExample) 2010-06-11
CA2274680C (en) 2003-11-18
HK1019704A1 (en) 2000-02-25
DE69708912D1 (de) 2002-01-17
DE122009000016I1 (de) 2009-06-25
EP0941094B1 (en) 2001-12-05

Similar Documents

Publication Publication Date Title
PT941094E (pt) Processo para o fabrico de suspensoes oftalmicas contendo brinzolamida
BR9406590A (pt) Processo para a produção de gelatina
BR9609277A (pt) Aço supermartensítico processo para a produção de artigos manufaturados de aço supermartensítico e os respectivos artigos manufaturados de aço supermartensítico
BR9508618A (pt) Processo integrado para a produção de lacteto
BR9403442A (pt) Silanos, processo para sua produção e aplicação dos ditos silanos
PT971913E (pt) Processo para a producao de estatinas semi-sinteticas atraves de novos intermediarios
BR9505245A (pt) Processo para produção de óxido de alquileno
PT102081A (pt) Aparelho de estampagem e processo para a fabricacao de placas de cablagem
BR9509842A (pt) Processo para produção de fosgênio
ITMI950056A0 (it) Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
BR9203999A (pt) Aplicador de hidrogel,e,processo para sua fabricacao
BR9403281A (pt) Peça de máquina aneliforme e processo para sua fabricação
PT770687E (pt) Processo para a producao de nicotinamida
BR9406201A (pt) Processo para a produção de difluoro-metano
BR9607413A (pt) Processo para produçao de pentafluoretano e tetrafluorcloroetano
PT1027315E (pt) Processo para a producao de n-butanol.
BR9505251A (pt) Processo para a fabricação de um composto e composto obtido
BR9804873A (pt) Processo para a produ-Æo de ironas
PT915988E (pt) Processo para a producao fermentativa de cefalosporinas desaciladas
PT1049723E (pt) Processo para o fabrico de inulina de chicoria
BR9609451A (pt) Processo para a produção de azeoh enanciomericamente puro e composto
BR9800565B1 (pt) processo para a produÇço de compostos de halogeno-o-hidroxidifenila.
BR9607743A (pt) Processo para produçao de diflúor metano e diflúor cloro metano
BR9600086A (pt) Processo para a produção de hidroxialcoxibenzofenonas
BR9006284A (pt) Processo para producao de norcanfano dicarbonitrilas